JP2024530714A - 超高分子量ポリマー及びそれを使用する方法 - Google Patents

超高分子量ポリマー及びそれを使用する方法 Download PDF

Info

Publication number
JP2024530714A
JP2024530714A JP2024510427A JP2024510427A JP2024530714A JP 2024530714 A JP2024530714 A JP 2024530714A JP 2024510427 A JP2024510427 A JP 2024510427A JP 2024510427 A JP2024510427 A JP 2024510427A JP 2024530714 A JP2024530714 A JP 2024530714A
Authority
JP
Japan
Prior art keywords
unit
monomer
group
water
soluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024510427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530714A5 (enExample
Inventor
エル． デビッドソン，カレン
ジー． ソーヤー，ウォレス
エス． サマリン，ブレント
ヴァルガス，フアン エム． ウルエニャ
Original Assignee
ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド filed Critical ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド
Publication of JP2024530714A publication Critical patent/JP2024530714A/ja
Publication of JP2024530714A5 publication Critical patent/JP2024530714A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24—Homopolymers or copolymers of amides or imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L43/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium or a metal; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Peptides Or Proteins (AREA)
JP2024510427A 2021-08-31 2022-08-30 超高分子量ポリマー及びそれを使用する方法 Pending JP2024530714A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163239027P 2021-08-31 2021-08-31
US63/239,027 2021-08-31
PCT/US2022/075616 WO2023034765A2 (en) 2021-08-31 2022-08-30 Ultra-high molecular weight polymers and methods of using the same

Publications (2)

Publication Number Publication Date
JP2024530714A true JP2024530714A (ja) 2024-08-23
JP2024530714A5 JP2024530714A5 (enExample) 2025-07-07

Family

ID=85385170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024510427A Pending JP2024530714A (ja) 2021-08-31 2022-08-30 超高分子量ポリマー及びそれを使用する方法

Country Status (10)

Country Link
US (1) US12624204B2 (enExample)
EP (1) EP4395791A4 (enExample)
JP (1) JP2024530714A (enExample)
KR (1) KR20240058883A (enExample)
CN (1) CN117999081A (enExample)
AU (1) AU2022339756A1 (enExample)
CA (1) CA3228099A1 (enExample)
MX (1) MX2024002537A (enExample)
TW (1) TW202327629A (enExample)
WO (1) WO2023034765A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250033149A (ko) * 2022-04-29 2025-03-07 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 초-고분자량 폴리머 및 이를 제조하고 사용하는 방법
CN116333197A (zh) * 2023-04-12 2023-06-27 厦门君德医药科技有限公司 胃肠道粘膜性聚合物、组合物及制备方法和应用
WO2025250735A1 (en) * 2024-05-29 2025-12-04 University Of Florida Research Foundation, Inc. Compositions comprising synthetic mucins and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080151180A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
WO2020061430A1 (en) * 2018-09-20 2020-03-26 Glyscend, Inc. Boronic acid polymers and methods of use
WO2021145249A1 (ja) * 2020-01-16 2021-07-22 東レ株式会社 医療デバイスの製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649722B2 (en) 1999-12-10 2003-11-18 Novartis Ag Contact lens
US8071121B2 (en) 2002-06-05 2011-12-06 University Of Florida Research Foundation, Incorporated Dispersions of microemulsions in hydrogels for drug delivery
US7988988B2 (en) 2005-11-21 2011-08-02 Bausch & Lomb Incorporated Contact lenses with mucin affinity
EP2364330B1 (en) 2008-11-06 2015-03-25 University Of Washington Multiblock copolymers
US8534031B2 (en) 2008-12-30 2013-09-17 Bausch & Lomb Incorporated Packaging solutions
US8410190B2 (en) 2009-09-22 2013-04-02 Coopervision International Holding Company, Lp Wettable hydrogel materials for use in ophthalmic applications and methods
US9452198B2 (en) * 2012-04-23 2016-09-27 Massachusetts Institute Of Technology Lectin conjugates for mucin hydration
US10196470B2 (en) 2016-05-16 2019-02-05 Benz Research And Development Corp. Hydrophobic intraocular lens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080151180A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Coatings and Solutions for Contact Lenses
WO2020061430A1 (en) * 2018-09-20 2020-03-26 Glyscend, Inc. Boronic acid polymers and methods of use
WO2021145249A1 (ja) * 2020-01-16 2021-07-22 東レ株式会社 医療デバイスの製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALAMELU MAHALINGAM ET A: "Inhibition of the transport of HIVusing a pH-responsive synthetic mucin-like polymer system", BIOMATERIALS, JPN6026027891, 1 May 2011 (2011-05-01), US, pages 8343 - 8355, ISSN: 0005903742 *
HUANG KUI ET AL: "Synthesis and Characterisation of Self-Assembling Block Copolymers Containing Bioadhesive End Groups", MACROMOLECULES, AMERICAN CHEMICAL SOCIETY, JPN6026027892, 11 March 2002 (2002-03-11), US, pages 397 - 406, ISSN: 0005903743 *

Also Published As

Publication number Publication date
US12624204B2 (en) 2026-05-12
CN117999081A (zh) 2024-05-07
AU2022339756A1 (en) 2024-02-08
US20230076717A1 (en) 2023-03-09
KR20240058883A (ko) 2024-05-03
MX2024002537A (es) 2024-05-24
WO2023034765A3 (en) 2023-04-13
EP4395791A4 (en) 2025-06-25
WO2023034765A2 (en) 2023-03-09
TW202327629A (zh) 2023-07-16
CA3228099A1 (en) 2023-03-09
EP4395791A2 (en) 2024-07-10

Similar Documents

Publication Publication Date Title
US12624204B2 (en) Ultra-high molecular weight polymers and methods of using the same
Liu et al. Ionic liquid functionalized non-releasing antibacterial hydrogel dressing coupled with electrical stimulation for the promotion of diabetic wound healing
Nguyen et al. Thermogels containing sulfated hyaluronan as novel topical therapeutics for treatment of ocular surface inflammation
Kundu et al. Silk sericin/polyacrylamide in situ forming hydrogels for dermal reconstruction
EP2496550B1 (en) Crosslinked zwitterionic hydrogels
Hiratani et al. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems
Hsiue et al. Development of in situ thermosensitive drug vehicles for glaucoma therapy
CN110431203B (zh) 经离子改性的有机硅、组合物和由其形成的医疗器材
Zhang et al. Antifouling and antibacterial zwitterionic hydrogels as soft contact lens against ocular bacterial infections
Jaiswal et al. Bi-layer composite dressing of gelatin nanofibrous mat and poly vinyl alcohol hydrogel for drug delivery and wound healing application: in-vitro and in-vivo studies
JPWO2002015911A1 (ja) コンタクトレンズ用潤滑剤及び装着液
TWI812881B (zh) 濕包裝軟性水凝膠眼睛插入物
Swain et al. Ocular delivery of felodipine for the management of intraocular pressure and inflammation: Effect of film plasticizer and in vitro in vivo evaluation
Deng et al. Rapid hemostatic antibacterial self-gelling powder based on methacryloylsulfonyl betaine and quaternized carboxymethyl chitosan
Deng et al. Poly (2-hydroxyethyl methacrylate-co-methacrylated hyaluronan-β-cyclodextrin) hydrogel: A potential contact lens material with high hydrophilicity, good mechanical properties and sustained drug delivery
Koehler et al. Alkaline poly (ethylene glycol)‐based hydrogels for a potential use as bioactive wound dressings
Luan et al. Bioactive cellulose-based thermoresponsive hydrogel with engineered ordered channels for rapid hemostasis and tissue regeneration
CA3180428A1 (en) In situ gelling zwitterionic hydrogel compositions, and methods of use thereof
Pedro et al. Gel-forming mucin improves lubricity across model gemini epithelial cell interfaces
US9421164B2 (en) Stimuli responsive adhesive gel for removal of foreign particles from soft tissue
TWI875050B (zh) 含有藥物組成物的隱形眼鏡及其製造方法
Pippa et al. pH-responsive polymeric nanoassemblies encapsulated into alginate beads: morphological characterization and swelling studies
CN118767195A (zh) 一种聚硫辛酸钠—聚硫辛酸复合黏附贴片及其制备方法和应用
Rivarola et al. Behavior of Macroporous Hydrogels as Scaffolds for Macrophage Cell Migration: Analysis of Immune Response and Wound Healing Treatment
Thammachat et al. Preparation and characterization of shellac/PVP iodine blend as antimicrobial film patch.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250627

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260707